The MS Society has launched a petition calling for the National Institute for Health and Care Excellence, NHS England and drug manufacturer Roche to rethink the decision to reject the first treatment to be licensed for the treatment of primary progressive multiple sclerosis.
Original Article: Charity launches petition calling for NICE to rethink MS drug decision